Nootropic profile
Unifiram
An AMPAkine nootropic structurally related to sunifiram but reportedly 1,000 times more potent than piracetam at enhancing long-term potentiation - acting as a positive allosteric modulator of AMPA receptors and activator of mGlu5 receptors with robust anti-amnesic effects in animal studies.
Educational only: this is not medical advice. Always check with a qualified healthcare professional before starting any supplement.
What is Unifiram?
Unifiram (DM-232) is a synthetic AMPAkine nootropic compound developed at the University of Firenze in Italy, structurally related to its more well-known sibling sunifiram (DM-235).
What it does for you
Community and editorial ratings, out of 5:
How to take it
- Community-reported dose: 2-5 mg per dose, taken sublingually for enhanced bioavailability. This is entirely based on anecdotal reports and extrapolation...
- Sublingual administration: Most users prefer sublingual dosing for faster onset (15-30 minutes) and potentially improved absorption compared to oral ingestion
- Frequency: Typically used 1-3 times daily, often in an as-needed fashion before cognitively demanding tasks
- Starting dose: Begin with 1-2 mg to assess individual sensitivity before increasing. The high potency relative to classical racetams demands conservative...
- Cycling: Due to the complete lack of long-term safety data, most protocols recommend cycling (e.g. 5 days on, 2 days off or 3 weeks on, 1 week off)
Watch out for
- No human clinical trials: Unifiram has never been tested in controlled human studies. All efficacy and safety data derives from rodent experiments and...
- Excitotoxicity risk: As an AMPAkine that enhances glutamatergic transmission, there is a theoretical risk of excitotoxicity at excessive doses, potentially...
- Seizure threshold: Enhanced AMPA and glutamate receptor activity may lower seizure threshold. Individuals with epilepsy or a history of seizures should...
- Unknown long-term effects: The consequences of chronic AMPA receptor potentiation and mGlu5 activation in humans are completely unknown. Receptor...
- Research chemical status: Unifiram is not approved for human consumption in any country. Quality, purity, and accurate dosing from research chemical vendors...
The science, if you're curious.
- Enhances the response of AMPA receptors to glutamate, increasing the amplitude and duration of excitatory postsynaptic currents critical for rapid synaptic...
- Facilitates LTP in hippocampal CA1 neurons via CaMKII and protein kinase C activation, strengthening synaptic connections involved in memory formation
- Activates metabotropic glutamate receptor 5, which modulates NMDA receptor function and intracellular calcium signalling to promote synaptic plasticity and...
- Stimulates cortical and hippocampal acetylcholine release, supporting attentional processes and working memory through enhanced cholinergic tone
Where to find it
- Research chemical vendors: Available from select nootropic suppliers as powder, typically in small quantities suitable for milligram-scale dosing
- No pharmaceutical production: Unifiram has never been manufactured by a pharmaceutical company and exists solely as a research compound
- Powder form: Most commonly supplied as the free base or hydrochloride salt in powder form, requiring an accurate milligram scale for safe dosing
- Solution form: Some vendors offer pre-dissolved solutions for volumetric dosing, which may improve dosing accuracy at such small quantities
Frequently asked
An AMPAkine nootropic structurally related to sunifiram but reportedly 1,000 times more potent than piracetam at enhancing long-term potentiation - acting as a positive allosteric modulator of AMPA receptors and activator of mGlu5 receptors with robust anti-amnesic effects in animal studies.
The main benefits people report from Unifiram are: Cognitive Enhancement, Creativity, Energy, Focus, Memory, Motivation.
Community-reported dose: 2-5 mg per dose, taken sublingually for enhanced bioavailability. This is entirely based on anecdotal reports and extrapolation...Sublingual administration: Most users prefer sublingual dosing for faster onset (15-30 minutes) and potentially improved absorption compared to o...
No human clinical trials: Unifiram has never been tested in controlled human studies. All efficacy and safety data derives from rodent experiments and...Excitotoxicity risk: As an AMPAkine that enhances glutamatergic transmission, there is a theoretical risk of excitotoxicity at excessive doses, pot...
Enhances the response of AMPA receptors to glutamate, increasing the amplitude and duration of excitatory postsynaptic currents critical for rapid synaptic...Facilitates LTP in hippocampal CA1 neurons via CaMKII and protein kinase C activation, strengthening synaptic connections involved in memory f...
Rate Unifiram
Log in to leave an overall rating.
What people are saying
Log in to leave a comment.
No comments yet. Be the first to share your experience.